Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stabilizer of axonemal microtubules 2 (SAXO2) is a protein encoded by the SAXO2 gene in humans. It is predicted to enable microtubule binding activity and is believed to function in the cytoskeleton, particularly within microtubules, the nucleus, and sperm flagellum. Although it belongs to a family of proteins associated with cilia and axonemal structures (related to the movement and stability of cilia and flagella), its precise biological functions remain incompletely characterized. SAXO2 has been linked to genetic conditions such as autosomal dominant deafness (type 68) and otosclerosis 1. Current evidence does not suggest SAXO2 is a direct therapeutic target, nor are there known drugs targeting it or specific biomarkers for clinical selection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stabilizer of axonemal microtubules 2 (SAXO2).